It is plausible that increased exosomal release of XIAP, Survivin and cIAP-2, and perhaps other survival and stress proteins might be linked to increased tumor aggressiveness and chemoresistance in AA-PCa patients. The gene discussed is XIAP; the disease is posterior cortical atrophy.